MEDICO Stock Overview
Medico Remedies Limited manufactures and sells pharmaceutical formulations in India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Medico Remedies Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹46.25 |
| 52 Week High | ₹100.70 |
| 52 Week Low | ₹44.50 |
| Beta | 0.12 |
| 1 Month Change | -8.05% |
| 3 Month Change | -47.23% |
| 1 Year Change | -44.78% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 91.12% |
Recent News & Updates
Recent updates
Medico Remedies Limited (NSE:MEDICO) Shares Slammed 33% But Getting In Cheap Might Be Difficult Regardless
Mar 22
Here's Why We Think Medico Remedies (NSE:MEDICO) Is Well Worth Watching
Jun 22What You Can Learn From Medico Remedies Limited's (NSE:MEDICO) P/E After Its 27% Share Price Crash
Jun 26Estimating The Fair Value Of Medico Remedies Limited (NSE:MEDICO)
Jun 03Shareholder Returns
| MEDICO | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -4.0% | 2.3% | 2.6% |
| 1Y | -44.8% | 56.7% | 45.0% |
Return vs Industry: MEDICO underperformed the Indian Pharmaceuticals industry which returned 57.2% over the past year.
Return vs Market: MEDICO underperformed the Indian Market which returned 46.6% over the past year.
Price Volatility
| MEDICO volatility | |
|---|---|
| MEDICO Average Weekly Movement | 8.8% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.0% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: MEDICO's share price has been volatile over the past 3 months.
Volatility Over Time: MEDICO's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 150 | Harshit Mehta | www.medicoremedies.com |
Medico Remedies Limited manufactures and sells pharmaceutical formulations in India. The company offers antibiotics and anti-infectives; beta-lactams- penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and steroidal preparations. It primarily exports its products.
Medico Remedies Limited Fundamentals Summary
| MEDICO fundamental statistics | |
|---|---|
| Market cap | ₹3.86b |
| Earnings (TTM) | ₹69.58m |
| Revenue (TTM) | ₹1.32b |
55.5x
P/E Ratio2.9x
P/S RatioIs MEDICO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MEDICO income statement (TTM) | |
|---|---|
| Revenue | ₹1.32b |
| Cost of Revenue | ₹1.01b |
| Gross Profit | ₹309.61m |
| Other Expenses | ₹240.03m |
| Earnings | ₹69.58m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.84 |
| Gross Margin | 23.53% |
| Net Profit Margin | 5.29% |
| Debt/Equity Ratio | 17.0% |
How did MEDICO perform over the long term?
See historical performance and comparison